ChemAbout

ChemAbout is a B2B platform where chemical buyers and suppliers discover each other.

Post a purchase requestList your products (for suppliers)
© 2026 ChemAbout
Compound Index|Demand Board|Insights|Exhibitions|Compliance|Help Center|Privacy Policy|Terms of Service|[email protected]
Home/Compounds/Pharmaceutical Intermediate/Fmoc-N-methyl-L-leucine
C22H25NO4
367.4 g/mol
Pharmaceutical IntermediateWarning

(2S)-2-({[(9H-fluoren-9-yl)methoxy]carbonyl}(methyl)amino)-4-methylpentanoic acid

CAS103478-62-2EC689-222-2
Category
Pharmaceutical Intermediate
Compound Class
Peptide
Primary Use
Pharmaceutical Intermediate

This compound is an Fmoc-protected, N-methylated derivative of L-leucine, used as a building block in solid-phase peptide synthesis. Its structure incorporates a fluorenylmethoxycarbonyl (Fmoc) group for temporary protection of the amino function, enabling the sequential assembly of peptides.

Building block for peptide synthesisResearch reagent for solid-phase peptide synthesis

Content scope: Information here supports chemical identification and industrial supply, research, and manufacturing contexts. It is not a therapeutic claim, medical advice, or drug-use instructions.

Sourcing this compound?

Post a free purchase request — no account needed. It reaches suppliers of this product, and replies go straight to your inbox.

Post a Purchase Request→Supplier? List your product for this CAS→

Related Compounds

SimilarStructure SimilarSimilarity 0.73

Fmoc-N-Methyl-L-alanine

CAS84000-07-7

pharmaceutical intermediate

ApplicationSame Use

Fmoc-N-methyl-L-isoleucine

CAS138775-22-1

pharmaceutical intermediate

ApplicationSame Use

FMoc-alpha-Me-D-Phe(2-F)-OH

CAS1315449-93-4

pharmaceutical intermediate

ApplicationSame Use

Fmoc-N-(2,4-dimethoxybenzyl)-Gly-OH

CAS166881-42-1

pharmaceutical intermediate

ApplicationSame Use

Fmoc-L-propargylglycine

CAS198561-07-8

pharmaceutical intermediate

ReferenceSame Category

2-Amino-4-(4-methylpiperazin-1-yl) benzoic acid tertbutyl ester

CAS1034975-35-3

pharmaceutical intermediate

ReferenceSame Category

4-(4-Methylpiperazin-1-yl)-2-(2,2,2-trifluoro-N-(tetrahydro-2H-pyran-4-yl)acetamido)benzoic acid 2,2,2-trifluoroacetate

CAS1034975-62-6

pharmaceutical intermediate

ReferenceSame Category

N-[1-(Hydroxymethyl)cyclopropyl]carbamic acid phenylmethyl ester

CAS103500-22-7

pharmaceutical intermediate

Related Reading

Therapeutic Peptides in 2026: This Year's Breakthroughs

2026 has been a concentrated year for peptide therapeutics. Efficacy reached a new high in late-stage trials, the obesity field moved beyond the incretins to amylin, the oral route reached weight management, and peptide-guided radioligand therapy kept advancing — each point tied to a specific 2025–2026 result.

Read more

Safety Reference

Harmful
Harmful
Warning
H302Harmful if swallowed
H312Harmful in contact with skin
H315Causes skin irritation
H319Causes serious eye irritation
H332Harmful if inhaled
H335May cause respiratory irritation
Identifiers
IUPAC Name

(2S)-2-[9H-fluoren-9-ylmethoxycarbonyl(methyl)amino]-4-methylpentanoic acid

InChIKey

BUJQSIPFDWLNDC-FQEVSTJZSA-N

SMILES

CC(C)C[C@@H](C(=O)O)N(C)C(=O)OCC1C2=CC=CC=C2C3=CC=CC=C13

Synonyms (12)
  • FMOC-MeLeu-OH
  • Fmoc-N-Me-L-Leu-OH
  • Fmoc-N-Me-Leu-OH
  • Fmoc-N-methyl-L-leucine
  • N-Fmoc-N-methyl-L-leucine

Sourcing this compound?

Post a free purchase request — no account needed. It reaches suppliers of this product, and replies go straight to your inbox.

Post a Purchase Request→Supplier? List your product for this CAS→